REG - Drax Group Plc - Total Voting Rights and Issue of Shares

DraxAnnouncement

01/05/2026 10:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260501:nRSA8020Ca&default-theme=true

RNS Number : 8020C  Drax Group PLC  01 May 2026

1 May 2026

 

Drax Group plc

("Drax" or the "Company"; Symbol: DRX)

Total Voting Rights and Issue of Shares

Total Voting Rights

 

In conformity with the Disclosure and Transparency Rules provision 5.6.1R, the
Company advises of the following:

 

That, as at 30 April 2026, the Company's issued share capital consisted of
432,526,196 ordinary shares of 11 (16)/(29) pence each, with each ordinary
share having one vote, of which 96,310,800 ordinary shares are held in
treasury.  Treasury shares do not carry voting rights.

 

Accordingly, the total number of voting rights in respect of these ordinary
shares is 336,215,396. This figure may be used by shareholders as the
denominator for the calculations by which they will determine if they are
required to notify their voting rights interest, or a change to that interest,
in the Company under the FCA's Disclosure and Transparency Rules.

 

Issue of Shares

 

In conformity with the PRM 1.6.4R, the Company announces that it has issued
and allotted 65,107 ordinary shares of 11 (16)/(29) pence each in the Company,
in connection with the Company's employee share plans set out below. The
shares were issued and allotted on various dates between 31 March 2026 and 30
April 2026. These shares were previously admitted to trading on the London
Stock Exchange Main Market under existing block admissions.

 

 Share plan                        Number of shares issued and allotted
 Sharesave Plan                    58,853
 Sharesave Plan 2024               6,254
 Total shares issued and allotted  65,107

 

Company details:

LEI: 549300YPSNTXR4ZHSR98

ISIN: GB00B1VNSX38

 

- - ENDS - -

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  TVRSSWSUFEMSESI



            Copyright 2019 Regulatory News Service, all rights reserved